What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.
about
The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysisThe influence of health systems on hypertension awareness, treatment, and control: a systematic literature reviewIs 50 cent the price of the optimal copayment? - a qualitative study of patient opinions and attitudes in response to a 50 cent charge on prescription drugs in a publicly funded health system in Ireland.Coping strategies used by patients infected with hepatitis C virus who are facing medication costs.Living arrangements, chronic diseases, and prescription drug expenditures among Korean elderly: vulnerability to potential medication underuse.Evaluation of factors affecting prescribing behaviors, in iran pharmaceutical market by econometric methodsCo-payments for general practitioners in Denmark: an analysis using two policy modelsInequalities in medicine use in Central Eastern Europe: an empirical investigation of socioeconomic determinants in eight countries.The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial FibrillationThe simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study.Targeting patients for multimorbid care management interventions: the case for equity in high-risk patient identification.The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysisPublic pensions and unmet medical need among older people: cross-national analysis of 16 European countries, 2004-2010Healthcare resources and expenditure in financial crisis: scenarios and managerial strategies.Health inequality--determinants and policies.Impact of income status on prognosis of acute coronary syndrome patients during Greek financial crisis.Financial arrangements for health systems in low-income countries: an overview of systematic reviews.Socioeconomic determinants of prescribed and non-prescribed medicine consumption in Austria.The painful effects of the financial crisis on Spanish health care.Prescribing in general practice for people with coronary heart disease; equity by age, sex, ethnic group and deprivation.Comparison of Canadian public medication insurance plans and the impact on out-of-pocket costs.What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension.The Great Recession and inequalities in access to health care: a study of unemployment and unmet medical need in Europe in the economic crisis.Fee-for-service payments and consultation length in general practice: a work–leisure trade-off model for French GPs
P2860
Q26829072-5F8E8777-1D0D-4890-9450-D3B8A19B8343Q28534975-2775511A-FE6F-4037-B2D1-4BEC787655AEQ34543684-E8E8AAD0-F369-4629-81D0-E3CB60098A26Q34977603-0A7A99C6-CA8E-430E-8514-3041584C1530Q34993573-5EBC6A23-2897-4BAD-8AE6-BF17B0E3B9F1Q35484194-8A665ACD-E86C-4238-9555-76EFB2FE5F6CQ36241366-FE6B03F2-7624-4330-A502-B4FDAFDA21CBQ36255229-F7F3D271-426A-4F24-B310-838E495683E7Q36620779-40A89AA3-141D-4F0C-85CF-57C86D1CC0F3Q37306469-E56C481E-AF67-4A5F-AFB8-810281C9FF9AQ37357646-2C0D0935-BE49-4A40-8F15-B7A77D89A88DQ37593438-F4716EFA-12C8-44B1-A852-D5E192AE3BBFQ37617031-719CD5A3-A563-4CB6-82E8-FE57744DDD76Q38041596-18B59BFE-0F5F-454B-ADA1-7CF8DAE99C16Q38059453-ED34F08F-8EB7-48D2-AA2F-736202094841Q41057117-7DA85ECA-0D24-4345-B2E7-502042DDC06FQ42722998-1E30BA46-DC1D-4CD3-8EAB-9477769B093EQ44044220-0F9D62F3-4392-45B7-AB75-F582F59EFB64Q45813363-F2B3BB80-610F-4278-8CFC-9A4D6842B755Q46017191-4E49FBCA-2150-4C04-8ADA-42ABFC669317Q47406180-57A9B333-9A0F-4F29-B0F1-2757B5970E2FQ47565817-4618A34A-C89A-4D51-B546-548179AEDAFCQ50099957-17C2DB3B-4DDE-45C7-928D-FB1CF40A5378Q58252346-DFD758EE-8F86-4BF6-9E6D-627CE8E15993
P2860
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
What impact do prescription dr ...... ce from high-income countries.
@ast
What impact do prescription dr ...... ce from high-income countries.
@en
type
label
What impact do prescription dr ...... ce from high-income countries.
@ast
What impact do prescription dr ...... ce from high-income countries.
@en
prefLabel
What impact do prescription dr ...... ce from high-income countries.
@ast
What impact do prescription dr ...... ce from high-income countries.
@en
P2093
P2860
P356
P1476
What impact do prescription dr ...... ce from high-income countries.
@en
P2093
Elias Mossialos
Marin C Gemmill
Sarah Thomson
P2860
P2888
P356
10.1186/1475-9276-7-12
P577
2008-05-02T00:00:00Z
P5875
P6179
1023458532